Developing and Implementing E-psychotherapy Program for Mental Health Challenges in Oncology and Palliative Care
Sponsored by Queen's University
About this trial
Last updated 3 years ago
Study ID
PSIY-699-20
Status
Recruiting
Type
Interventional
Phase
N/A
Placebo
No
Accepting
18 to 55 Years
All
Not accepting
Healthy Volunteers
Trial Timing
Ended 2 years ago
What is this trial about?
The demand for mental health problems, particularly depression and anxiety, is three times
greater in Oncology and Palliative Care Centres than in the general population. There are
unique factors in this population that make them more susceptible to mental health
challenges. The disease itself, the adjustment to a chronic/fatal diagnosis, and the
treatment options can all perpetuate the development of mental illness. Despite the
well-established association, there have been barriers to access suitable treatment for these
patients.
Online Psychotherapy is an effective treatment option that may address many of these
barriers. This modality has been proven effective in addressing depression and anxiety in
other populations. To date, there has been no psychotherapy module developed specifically for
oncology and palliative care patients to our knowledge. The aim is to establish the first
academic e-psychotherapy treatment option to address mood and anxiety disorders in oncology
and palliative care patients. The investigators will use the Online Psychotherapy Tool
(OPTT), a secure cloud-based platform for online delivery of e-CBT, developed by the PI.
The proposed study aims to establish the feasibility and effectiveness of delivering online
psychotherapy to oncology and palliative care patients who have a comorbid depressive or
anxiety disorder. The patients will be enrolled in an 8-week program with a combination of
cognitive behavioural therapy (CBT) and Mindfulness techniques delivered via a series of
modules. They will receive individualized feedback from a trained therapist weekly. It is
hypothesized that delivering this psychotherapeutic intervention in this manner will have
great adherence. The aim is to prove that it will improve the quality of life and decrease
symptoms of depression and anxiety in this underserved patient population.
What are the participation requirements?
Inclusion Criteria
- Diagnosed with depressive or anxiety disorder due to another medical condition in the context of cancer or palliative care
- competence to consent and participate
- speak and read English
- consistent and reliable access to the internet
Exclusion Criteria
- acute hypomanic/manic episodes
- acute psychosis
- severe alcohol or substance use disorder
- active suicidal or homicidal ideation
- received CBT in the past year or are currently receiving CBT
Locations
Location
Status
Recruiting